Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | -96.36% |
|
-.--% | -99.07% |
01-17 | Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
2023 | Innovation1 Biotech Inc. announced that it has received $0.15 million in funding | CI |
Performance
1 day | -96.36% | ||
3 months | -96.36% | ||
6 months | -99.07% | ||
Current year | -99.07% | ||
1 year | -99.56% | ||
3 years | -99.97% | ||
5 years | -99.99% |
Volumes
marketsBasic data
Highs and lows
![Extreme 0.0008](/images/extremecours_fleche.png)
![Extreme 0.0008](/images/extremecours_fleche.png)
![Extreme 0.0008](/images/extremecours_fleche.png)
![Extreme 0.0008](/images/extremecours_fleche.png)
![Extreme 0.0008](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Shell Companies
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-96.36% | -.--% | -99.07% | -99.56% | 17.98K | ||
-10.84% | +18.40% | +87.14% | +158.28% | 5.79B | ||
0.00% | 0.00% | +98.02% | +100.00% | 1.25B | ||
0.00% | -0.14% | +2.57% | +4.46% | 986M | ||
+4.70% | +13.88% | +32.87% | +92.31% | 869M | ||
0.00% | +0.09% | +2.20% | +5.02% | 667M | ||
+4.35% | +5.26% | +7.72% | - | 653M | ||
-.--% | -.--% | -.--% | -.--% | 600M | ||
0.00% | -0.25% | +10.28% | +2.11% | 536M | ||
-.--% | -.--% | - | - | 500M | ||
+2.41% | +6.09% | -5.20% | - | 470M | ||
+12.50% | -.--% | -.--% | +12.50% | 450M | ||
-.--% | -2.56% | - | - | 445M | ||
+0.05% | +0.10% | - | - | 442M | ||
+5.13% | +10.60% | -81.06% | - | 425M | ||
-0.05% | -0.19% | +1.25% | - | 401M | ||
Average | -4.88% | +3.20% | +4.36% | +30.57% | ||
Weighted average by Cap. | -3.24% | +8.84% | +48.38% | +101.90% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -99.07% | ||
2023 | -9.71% | ||
2022 | -93.71% | ||
2021 | -69.36% | ||
2020 | -30.43% | ||
2019 | -42.50% | ||
2018 | -96.52% | ||
2017 | +21.05% |
- Stock Market
- Equities
- IVBT Stock
- Quotes Innovation1 Biotech Inc.